What is the focal therapy for prostate cancer?

What is the focal therapy for prostate cancer?

Written by: Dr. Juan Uría González-Tova
Published: | Updated: 10/08/2018
Edited by: Top Doctors®

Prostate cancer is the most common in men of Catalonia, affecting 1 in 6, and the third deadliest, behind lung cancer and colorectal. Despite the statistics, specialists Urology claim that less than 3 of every 100 men die of this disease because it usually grows very slowly.

focal prostate therapy The focal therapy in prostate cancer is proving to be an alternative source to radical treatment might as preserving sexual function and urinary continence patient. Still, validation studies on a large scale need to be able to offer a standardized way.

Focal therapy aims to treat prostate cancer with a similar approach to other malignant solid organ pictures. Treatment is focused in the area of ​​cancer and surrounding normal tissues in order to preserve the tissue and consequently organ function. Thus, the risk of damage nerves, muscles, urinary sphincter, bladder and rectum neighbors can be considerably reduced.

 

Using focal therapy of prostate cancer

Energy sources that can be used in the focal therapy for prostate cancer:

  • HIFU (High Intensity Focused Ultrasound), developed in the early 1990s by the French Institute of Medical Research, the University Hospital of Lyon and EDAP TMS. It has been used worldwide routinely for more than 20 years in more than 40,000 treatments performed in 3 generations of commercial devices; the Ablatherm Maxis (1993-2005), Ablatherm®, integrated imaging (since 2005) and focal One® (since 2013) to treat prostate cancer by creating precise coagulation necrosis and irreversible tissue target while preserving the surrounding tissue.
  • cryotherapy. In 1996, prostate cryoablation longer considered experimental to be recognized with a treatment option for prostate cancer by the American Urological Association (AUA).

Prostatic Cryosurgery is the in situ and controlled freezing of the prostate tissue in order to ablate a portion or the entire prostate gland to achieve eradication preserving the anatomic integrity of adjacent structures. The destructive effects of cryosurgery can be grouped into two mechanisms: cell damage and vascular damage Prostatic Cryosurgery is the in situ and controlled freezing of the prostate tissue in order to ablate a portion or the entire prostate gland to achieve eradicate the disease while preserving the anatomical integrity of structures vecinas.7Los destructive effects of cryosurgery can be grouped into two mechanisms: cell damage and vascular damage.

*Translated with Google translator. We apologize for any imperfection
Dr. Juan Uría González-Tova

By Dr. Juan Uría González-Tova
Urology

Dr. Uría González-Tova is an eminence in the field of urology. Bachelor of Medicine at the University of Oviedo and two Masters in Bioinformatics and Biotechnology, Dr. exercises his professional work as Head of Urology Unit at the Hospital Consortium of Vic. Asismimo, the doctor received the award for the best doctoral thesis, with qualification Cum Laude, of the Catalan Society of Urology. He is also an active member of several associations in the sector.

*Translated with Google translator. We apologize for any imperfection


TOPDOCTORS utiliza cookies propias y de terceros para facilitar su experiencia como usuario de nuestra web y captar datos estadísticos mediante el análisis de sus datos de navegación. Si usted continúa con la navegación, entendemos que nos ofrece su consentimiento para el uso de cookies. Puede cambiar la configuración de cookies u obtener más información here.